Terlipressin

For research use only. Not for therapeutic Use.

  • CAT Number: I001772
  • CAS Number: 14636-12-5
  • Molecular Formula: C52H74N16O15S2
  • Molecular Weight: 1227.37
  • Purity: 99%
Inquiry Now

Terlipressin(Cat No.:I001772)is a synthetic vasopressin analog used primarily to treat hepatorenal syndrome (HRS) and variceal bleeding in patients with cirrhosis. It works by constricting blood vessels, particularly in the splanchnic circulation, which reduces portal pressure and improves kidney function. Terlipressin helps manage acute variceal hemorrhage by controlling bleeding and stabilizing patients with liver cirrhosis. Its vasoconstrictive properties make it an effective therapy in emergency situations, offering a targeted approach to improving hemodynamic stability and enhancing survival rates in patients with serious liver-related complications.


Catalog Number I001772
CAS Number 14636-12-5
Molecular Formula C52H74N16O15S2
Purity 99%
Target V1AR
Target Protein

P37288

Solubility DMSO ≥ 12.3 mg/mL
Appearance Solid
Storage Dry, dark and at 2 - 8 °C for six months or -20°C for two years.
IC50 IC50: 25 nM
IUPAC Name (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide
InChI InChI=1S/C52H74N16O15S2/c53-17-5-4-9-31(45(76)60-23-41(57)72)63-51(82)38-10-6-18-68(38)52(83)37-27-85-84-26-36(61-44(75)25-59-43(74)24-58-42(73)22-54)50(81)65-34(20-29-11-13-30(69)14-12-29)48(79)64-33(19-28-7-2-1-3-8-28)47(78)62-32(15-16-39(55)70)46(77)66-35(21-40(56)71)49(80)67-37/h1-3,7-8,11-14,31-38,69H,4-6,9-10,15-27,53-54H2,(H2,55,70)(H2,56,71)(H2,57,72)(H,58,73)(H,59,74)(H,60,76)(H,61,75)(H,62,78)(H,63,82)(H,64,79)(H,65,81)(H,66,77)(H,67,80)/t31-,32-,33-,34-,35-,36-,37-,38-/m0/s1
InChIKey BENFXAYNYRLAIU-QSVFAHTRSA-N
SMILES C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N
Reference

<p style=/line-height:25px/>
<br>[1]. Jao YT et al. Refractory torsade de pointes induced by terlipressin (Glypressin). Int J Cardiol, 2016 Jul 30, 222:135-140.
</p>

Request a Quote